Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06719102 · ClinicalTrials.gov registry record · NA
Mothers and CareGivers Investing in Children Study 2.0
A NA study of Childhood Obesity Prevention and Parenting Behavior, sponsored by University of Texas at Austin.
- Recruiting
- Registry status
- NA
- Development phase
- 266
- Enrollment target
- 2
- Study locations
NCT06719102: Recruiting NA study of Childhood Obesity Prevention and Parenting Behavior, sponsored by University of Texas at Austin.
NCT06719102 is a NA study of Childhood Obesity Prevention and Parenting Behavior that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 266 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06719102, a NA study of Childhood Obesity Prevention and Parenting Behavior, is actively recruiting participants, sponsored by University of Texas at Austin.
- RECRUITING
- Registry status
- NA
- Development phase
- 266 participants
- Enrollment target
- 2
- Study locations
Study Summary
The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that has been successfully implemented with families as part of the MAGIC 1.0 program trial (IRB#: 2015040017). * The primary aim is to investigate each intervention's impact on infant BMIZ at 13 months. * The investigators will also assess the effect of MAGIC-FEED on caregiver nutrition knowledge and feeding practices, responsive feeding, infant diet, and child self-regulatory abilities and assess how these factors impact child self-regulation of eating and adiposity. * Finally, the investigators will determine if the interventions demonstrate the factors necessary to be a successful intervention as determined by the RE-AIM and PRISM frameworks.
Primary Outcome
Assessed via anthropometrics and WHO Child Growth Standards.
Conditions Studied
Interventions
- BEHAVIORAL MAGIC-FEED
- BEHAVIORAL MAGIC-SAFE
Study Locations (2)
Texas
- Sarah M. & Charles E. Seay Building - Austin
- Dell Pediatric Research Institute - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 266 participants |
| Start Date | 2025-02-13 |
| Est. Completion | 2029-12-31 |
| Phase | NA |
What NCT06719102 shows while recruiting
NCT06719102 is an interventional study that assigns participants to a tested intervention. The registered 266 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 3 conditions, with Childhood Obesity Prevention appearing as the primary indexed condition, and to 2 interventions - of which MAGIC-FEED is the first listed.
NCT06719102 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06719102 about?
NCT06719102 is a clinical study titled "Mothers and CareGivers Investing in Children Study 2.0". The study will use a longitudinal, randomized control trial design to determine intervention impact on parent and child behaviors, and infant health. The two intervention groups include: 1) MAGIC-FEED+; and 2) MAGIC-SAFE. This trial is an efficacy trial of the MAGIC-FEED and MAGIC-SAFE program that ...
What is the current status of trial NCT06719102?
This trial is currently recruiting. It is a NA study. The enrollment target is 266 participants. The study started on 2025-02-13. Estimated completion is 2029-12-31.
What conditions does trial NCT06719102 study?
This clinical trial studies the following conditions: Childhood Obesity Prevention, Parenting Behavior, Infant Growth.
What interventions are being tested in trial NCT06719102?
The interventions under investigation include: MAGIC-FEED (BEHAVIORAL), MAGIC-SAFE (BEHAVIORAL).
Who is sponsoring clinical trial NCT06719102?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06719102 being conducted?
This trial has 2 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Childhood Obesity Prevention
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06719102's enrollment target sits among peer trials
266 395th of 2000 higher than 1,606 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05098652 · 266 participants · NA
Coaching Dementia Caregivers to Master Care-Resistant Behavior
- NCT06088277 · 266 participants · NA
Texting to Reduce Human Immunodeficiency Virus (HIV) Risk
- NCT06261814 · 266 participants · Phase 2
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
- NCT06312124 · 266 participants · NA
A Study of Opportunistic Salpingectomy to Prevent Ovarian Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI